PT  - JOURNAL ARTICLE
AU  - Carolina, Torres
AU  - Laura, Mojsiejczuk
AU  - Dolores, Acuña
AU  - Sofía, Alexay
AU  - Ariel, Amadio
AU  - Paula, Aulicino
AU  - Humberto, Debat
AU  - Franco, Fernández
AU  - Stephanie, Goya
AU  - Guido, König
AU  - Mercedes, Nabaes Jodar
AU  - Luis, Pianciola
AU  - Sofía, Bengoa
AU  - Marco, Cacciahue
AU  - Cecilia, Camussone
AU  - José, Dus Santos María
AU  - Florencia, Eberhardt María
AU  - Ailen, Fernandez
AU  - Inés, Gismondi María
AU  - Matías, Irazoqui
AU  - Silvina, Lusso
AU  - Nathalie, Marquez
AU  - Marianne, Muñoz
AU  - Mónica, Natale
AU  - Belén, Pisano
AU  - Andrea, Puebla
AU  - Viviana, Re
AU  - Ezequiel, Sosa
AU  - Jonathan, Zaiat
AU  - Sebastián, Zunino
AU  - Darío, Do porto
AU  - Elina, Acevedo María
AU  - Cristina, Alvarez Lopez
AU  - Laura, Álvarez María
AU  - Patricia, Angeleri
AU  - Andrés, Angelletti
AU  - Manuel, Arca
AU  - Gabriela, Barbas
AU  - Ana, Bertone
AU  - Agustina, Bonnet
AU  - Ignacio, Bourlot
AU  - Alejandro, Castello
AU  - Gonzalo, Castro
AU  - Carolina, Ceriani
AU  - Carlos, Cimino
AU  - Julián, Cipelli
AU  - María, Colmeiro
AU  - Andrés, Cordero
AU  - Carolina, Cristina
AU  - Sofia, Di Bella
AU  - Regina, Ercole
AU  - Yesica, Espasandin
AU  - Carlos, Espul
AU  - Andrea, Falaschi
AU  - Facundo, Fernandez Moll
AU  - Andrea, Gatelli
AU  - Sandra, Goñi
AU  - Estela, Jofré María
AU  - José, Jaramillo
AU  - Natalia, Labarta
AU  - Agustina, Lacaze María
AU  - Rocio, Larreche
AU  - Viviana, Leiva
AU  - Gustavo, Levin
AU  - Erica, Luczak
AU  - Marcelo, Mandile
AU  - Carla, Massone
AU  - Melina, Mazzeo
AU  - Carla, Medina
AU  - Belén, Monaco
AU  - Luciana, Montoto
AU  - Viviana, Mugna
AU  - Alejandra, Musto
AU  - Guillermo, Ojeda
AU  - Carolina, Pintos
AU  - Marcia, Pozzati
AU  - Marilina, Rahhal
AU  - Claudia, Rechimont
AU  - Federico, Remes Lenicov
AU  - Gabriela, Rompato
AU  - Vanesa, Seery
AU  - Leticia, Siri
AU  - Julieta, Spina
AU  - Cintia, Streitenberger
AU  - Ariel, Suárez
AU  - Jorgelina, Suárez
AU  - Paula, Sujanski
AU  - Manuel, Talia Juan
AU  - Clara, Theaux
AU  - Guillermo, Thomas
AU  - Marina, Ticeira
AU  - Estefanía, Tittarelli
AU  - Rosana, Toro
AU  - Osvaldo, Uez
AU  - Belén, Zaffanella María
AU  - Cecilia, Ziehm
AU  - Martin, Zubieta
AU  - ,
AU  - Alicia, Mistchenko
AU  - Laura, Valinotto
AU  - Mariana, Viegas
TI  - Surveillance of SARS-CoV-2 variants in Argentina: detection of Alpha, Gamma, Lambda, Epsilon and Zeta in locally transmitted and imported cases
AID  - 10.1101/2021.07.19.21260779
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.07.19.21260779
4099  - http://medrxiv.org/content/early/2021/07/22/2021.07.19.21260779.short
4100  - http://medrxiv.org/content/early/2021/07/22/2021.07.19.21260779.full
AB  - Molecular surveillance of SARS-CoV-2 variants was performed on a total of 2,406 samples from the capital city and nine provinces of Argentina, during 30 epidemiological weeks (EW) that covered the end of the first wave and the beginning of the ongoing second wave of the COVID-19 pandemic in the country (EW 44/2020 to EW 20/2021). The surveillance strategy was mainly based on Sanger sequencing of a Spike coding region that allows the simultaneous identification of signature mutations associated with worldwide circulating variants. In addition, whole SARS-CoV-2 genome sequences were obtained from 456 samples. The main variants found were Gamma, Lambda and Alpha, and to a lesser extent, Zeta and Epsilon. Whereas Gamma dominated in different regions of the country, both Gamma and Lambda prevailed in the most populated area, the metropolitan region of Buenos Aires (MABA), although showing a heterogeneous distribution along this region. This cost-effective surveillance protocol allowed for a rapid response in a limited access to resources scenario, added information on the expansion of the Lambda variant in South America and contributed to the implementation of public health measures to control the disease spread in Argentina.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Proyecto IP COVID-19 N 08 and Focem COF 03/11 Covid-19.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All relevant ethical guidelines have been appropriately followed. The study was approved by the Ethics Committee of the Hospital de Ninos Ricardo Gutierrez, CABA, Argentina.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe sequences obtained in this study can be found in the online repository GISAID.